Aims and Objectives
Viral infections are spread worldwide and result in significant morbidity and mortality. Globally, viral hepatitis is of particular concern as it was the seventh leading cause of death in 2013, up from the 10th leading cause in 1990. The most important hepatitis viruses are hepatitis B and C. About 2 billion people in the world have evidence of past or current HBV infection, with 240 million chronic carriers of HBsAg. HBV leads to 650,000 deaths annually as a result of viral hepatitis–induced liver disease. An estimated 71 million people are chronically infected with HCV worldwide. About 55-85% of these people infected progress to chronic HCV infection, with a 15-30% risk of developing liver cirrhosis within two decades. Approximately 399,000 people die each year from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma. Antiviral medicines can cure more than 95% of persons with hepatitis C infection, thereby reducing the risk of death from liver cancer and cirrhosis, but access to diagnosis and treatment is low. Hepatitis can also result from infection by other A- E hepatitis and fourteen other families of viruses.
Aim of the Viral Infection Working Group
To work together at an international level, in multiple areas related to viral infections with regards to education and research activities. Participation of junior colleagues in all activities is strongly encouraged.
1. To hold “Viral/Hepatitis Symposiums” in all future meetings whether national, regional or international.
2. To carry out relevant research activities.
3. To carry out a series of “post graduate courses in viral infections”.
4. To link and synergize with other medical societies and stakeholders working around viral infections